Factor Model (net +1.0)
Factor Model
net +1.0 2.1 / 10Organigram Q2 Sales Miss, Margins Pressured
Watch: Q3 earnings and margin trends will indicate if operational improvements offset Q2 pressures and validate raised revenue guidance.
Organigram Global posted a Q2 loss of $0.01 per share and revenue of $43.59 million, missing $52.06 million consensus. Adjusted EBITDA crashed 82% to $0.9 million. Gross margin fell to 31% from 33% due to mix changes and higher production costs despite raised fiscal 2026 revenue guidance above $350 million versus prior $300 million.
The earnings miss and margin pressure highlight operational challenges amid cost pressures, overshadowing optimistic raised revenue targets and pointing to near-term profitability risks.
Evidence
Fundamentals & Data ▾
Recent transactions
Track Record (1/1 correct) ▾
Direction History
1/1 correct at 5 daysKeep reading the market
Direction shifts, insider clusters, filing red flags, and earnings call changes stay published on the site.